Journal of Cancer Therapy

Volume 4, Issue 4 (June 2013)

ISSN Print: 2151-1934   ISSN Online: 2151-1942

Google-based Impact Factor: 0.30  Citations  h5-index & Ranking

Suppression of NF-κB/p65 Inhibits the Proliferation in Oral Squamous Cancer Cells

HTML  Download Download as PDF (Size: 749KB)  PP. 891-897  
DOI: 10.4236/jct.2013.44100    3,600 Downloads   5,897 Views  Citations

ABSTRACT

Object: Hypoxia occurs when oxygen tension drops below normal limits, and malignant tumors often experience hypoxia, which activates the expression of genes through oxygen-sensitive transcription factors, including the hypoxiainducible factor (HIF) and the nuclear factor-κB (NF-κB). NF-κB pathway represents an attractive therapeutic target in both cancer cells and ischemic cells, which involves immune response. To investigate the expression of NF-κB target genes in oral squamous cancer carcinoma (OSCC) under hypoxia, we performed cDNA plate array analyses of 23 NF-κB-regulated genes in different cell lines. Our aim was to clarify the functions of NF-κB in OSCC under hypoxia. Results: We conducted an NF-κB reporter assay to examine NF-κB activation under hypoxia. This luciferase-based reporter assay showed that hypoxia induced NF-κB activation after 24 h of hypoxia. We also found that vascular endothelial growth factor-C (VEGF-C) of NF-κB-regulated genes was upregulated in both cell lines under hypoxia. We then tested the influence of NF-κB/p65 knockdown on these cells and NF-κB/p65 knockdown inhibited the proliferation of OSCC cells by colony assay. Conclusion: Based on these findings, we postulate that one mechanism by which hypoxic OSCC cells may involve NF-κB-mediated upregulation. Our results also indicate that the knockdown of NF-κB/p65 subunit lead to growth inhibition during hypoxia in OSCC cells. These results suggest that knockdown of NF-κB/p65 subunit could be a potential therapeutic option for patients with OSCC.

Share and Cite:

N. Anbo, K. Ogi, Y. Sogabe, M. Shimanishi, T. Kaneko, H. Dehari, A. Miyazaki and H. Hiratsuka, "Suppression of NF-κB/p65 Inhibits the Proliferation in Oral Squamous Cancer Cells," Journal of Cancer Therapy, Vol. 4 No. 4, 2013, pp. 891-897. doi: 10.4236/jct.2013.44100.

Cited by

[1] NFκB (RelA) mediates transactivation of hnRNPD in oral cancer cells
Scientific reports, 2022
[2] Critical pathways of oral squamous cell carcinoma: molecular biomarker and therapeutic intervention
Medical Oncology, 2022
[3] Correlation between Decreased Nuclear Factor Kappa Beta (NFKβ), Kras, and Braf Genes' Expression and Enhanced Chemosensitivity of Human Squamous …
LATİF… - Turkish Journal of …, 2021
[4] The frequency of high-risk human papillomavirus types, HPV16 lineages, and their relationship with p16 INK4a and NF-κB expression in head and neck squamous …
2021
[5] Correlation between Decreased Nuclear Factor Kappa Beta (NFKβ), Kras, and Braf Genes’ Expression and Enhanced Chemosensitivity of Human Squamous Cell Carcinoma Cells to 5-fluorouracil and/or Mesenchymal Stem Cells-derived Microvesicles
TURKISH JOURNAL of ONCOLOGY, 2021
[6] Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC
Oral Oncology, 2018
[7] Molecular pathways of oral cancer that predict prognosis and survival: A systematic review
2018
[8] Analyzing the Role of TNF-α and Autophagy in Regulation of TGF-β Induced Epithelial to Mesenchymal Transition in Cancer Cells
2018
[9] Gene Therapy in the Treatment and Prevention of Oral Cancer: An Overview
International Journal of Advanced Health Sciences, 2015
[10] NF-κB acts as a multifunctional modulator in bone invasion by oral squamous cell carcinoma
Oral Science International, 2015
[11] Correlation between Decreased Nuclear Factor Kappa Beta (NFKΒ), Kras, and Braf Genes

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.